PMID- 34212905 OWN - NLM STAT- MEDLINE DCOM- 20210712 LR - 20210824 IS - 2531-6745 (Electronic) IS - 0392-4203 (Print) IS - 0392-4203 (Linking) VI - 92 IP - 3 DP - 2021 Jul 1 TI - Understanding the association between endothelial dysfunction and left ventricle diastolic dysfunction in development of coronary artery disease and heart failure. PG - e2021204 LID - 10.23750/abm.v92i3.11495 [doi] LID - e2021204 AB - Cardiovascular diseases (CVDs) have been the most common cause of death worldwide for decades. Until recently the most affected patients were middle-aged and elderly, predominantly men, with more frequent ST elevation myocardial infarction (STEMI) caused by obstructive coronary artery disease (CAD). However, in the last two decades we have noticed an increased incidence of ischemia with non-obstructive coronary arteries (INOCA), which includes myocardial infarction with non-obstructive coronary arteries (MINOCA) and non-myocardial infarction syndromes, such as microvascular and vasospastic angina, conditions that have been particularly pronounced in women and young adults - the population we considered low-risky till than. Therefore, it has become apparent that for this group of patients conventional methods of assessing the risk of future cardiovascular (CV) events are no longer specific and sensitive enough. Heart failure with preserved ejection fraction (HFpEF) is another disease, the incidence of which has been rising rapidly during last two decades, and predominantly affects elderly population. Although the etiology and pathophysiology of INOCA and HFpEF are complex and not fully understood, there is no doubt that the underlying cause of both conditions is endothelial dysfunction (ED) which further promotes the development of left ventricular diastolic dysfunction (LVDD). Plasma biomarkers of ED, as well as natriuretic peptides (NPs), have been intensively investigated recently, and some of them have great potential for early detection and better assessment of CV risk in the future. FAU - Susic, Livija AU - Susic L AD - Department of Internal Medicine, Osijek-Baranja County Health Center, Osijek, Croatia and Josip Juraj Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia. livija.susic@gmail.com. FAU - Maricic, Lana AU - Maricic L AD - Cardiology, University Hospital Centre Osijek, Osijek, Croatia; Josip Juraj Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia. dr.lmaricic@gmail.com. FAU - Vincelj, Josip AU - Vincelj J AD - Josip Juraj Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia. josip.vinceljgg@gmail.com. FAU - Vadoci, Milena AU - Vadoci M AD - 1Department of Internal Medicine, Osijek-Baranja County Health Center, Osijek, Croatia. milenavadoci23@gmail.com. FAU - Susic, Tihomir AU - Susic T AD - The Information Institute Osijek, Osijek, Croatia. tihomir.susic@gmail.com. LA - eng PT - Journal Article DEP - 20210701 PL - Italy TA - Acta Biomed JT - Acta bio-medica : Atenei Parmensis JID - 101295064 SB - IM MH - Aged MH - *Coronary Artery Disease/etiology MH - Female MH - *Heart Failure/epidemiology/etiology MH - Heart Ventricles MH - Humans MH - Male MH - Middle Aged MH - Stroke Volume MH - *Ventricular Dysfunction, Left/etiology PMC - PMC8343725 COIS- Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article. EDAT- 2021/07/03 06:00 MHDA- 2021/07/13 06:00 PMCR- 2021/01/01 CRDT- 2021/07/02 09:03 PHST- 2021/03/23 00:00 [received] PHST- 2021/04/07 00:00 [accepted] PHST- 2021/07/02 09:03 [entrez] PHST- 2021/07/03 06:00 [pubmed] PHST- 2021/07/13 06:00 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - ACTA-93-204 [pii] AID - 10.23750/abm.v92i3.11495 [doi] PST - epublish SO - Acta Biomed. 2021 Jul 1;92(3):e2021204. doi: 10.23750/abm.v92i3.11495.